Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank55
3Y CAGR+0.2%
5Y CAGR+2.9%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+0.2%/yr
Annual compound
5Y CAGR
+2.9%/yr
Consistent
Percentile
P55
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 20.00% | +27.1% |
| 2024 | 15.74% | -24.8% |
| 2023 | 20.92% | +5.1% |
| 2022 | 19.90% | +3.9% |
| 2021 | 19.16% | +10.4% |
| 2020 | 17.35% | +81.8% |
| 2019 | 9.54% | +906.7% |
| 2018 | -1.18% | -104.5% |
| 2017 | 26.23% | -13.0% |
| 2016 | 30.15% | - |